Indications and uses
TL Gard Rx tablets are indicated for nutritional support and folic acid supplementation.
TL Gard Rx tablets are indicated for nutritional support and folic acid supplementation.
Adults - one tablet daily or as prescribed by a physician.
Rx Only
TL Gard Rx are round, light pink, speckled, film-coated tablets debossed "TL015" and intended for oral administration.
| Supplement Facts Servings per Bottle: 100 | ||
|---|---|---|
| Serving Size: 1 tablet Each tablet contains | % DV for Adults Only | |
| Folic Acid | 2.2 mg | 550% |
| Vitamin B6 (pyridoxine HCl) | 25 mg | 1250% |
| Vitamin B12 (cyanocobalamin) | 1 mg | 167% |
Inactive Ingredients:
Microcrystalline Cellulose, Di Cal Phosphate, TriPotassium Citrate, Citric Acid, Sodium Carboxymethyl Cellulose, Stearic Acid, Silicon Dioxide, Dextrin, Dextrose (corn), Lecithin, Sodium Citrate.
TL Gard Rx tablets are indicated for nutritional support and folic acid supplementation.
This product is contraindicated in patients with known history of hypersensitivity to any of the ingredients.
THIS PRODUCT CONTAINS SOY.
Folic acid when taken in doses above 0.1 mg daily, may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.
Safety and effectiveness in pediatric patients have not been established.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Adults - one tablet daily or as prescribed by a physician.
TL Gard Rx tablets are available in bottles of 100 tablets.
Product Code: 13811-527-01
Store at 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F) [See USP controlled room temperature]. Protect from light and moisture.
Dispense in a tight container with a child-resistant closure.
Call your doctor about side effects. You may report side effects by calling 888 9 TRIGEN (888-987-4436).
All prescriptions using this product shall be pursuant to statutes as applicable. This is not an Orange Book product. There are no implied or explicit claims on therapeutic equivalence.
KEEP OUT OF REACH OF CHILDREN.
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13811-527-01 | EA - Each | 13811-527 | ab786c7c-9d48-4249-8b55-173c2b2ae04f | 1 | 2013-06-04 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 2 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 2 | |
| pyridoxine Hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 2 | |
| cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 2 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 2 | |
| PYRIDOXINE | ACTIVE MOIETY | KV2JZ1BI6Z | 2 | |
| Calcium Phosphate, Dibasic, Anhydrous | INACTIVE INGREDIENT | L11K75P92J | 2 | |
| carboxymethylcellulose sodium | INACTIVE INGREDIENT | K679OBS311 | 2 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| citric acid monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 2 | |
| dextrose | INACTIVE INGREDIENT | IY9XDZ35W2 | 2 | |
| icodextrin | INACTIVE INGREDIENT | 2NX48Z0A9G | 2 | |
| potassium citrate anhydrous | INACTIVE INGREDIENT | 86R1NVR0HW | 2 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| sodium citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | 2 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 13811-527 | 13811-527-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SOLUTION / ORAL | 280 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / NASAL | 2.8 mg/1ml | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| carboxymethylcellulose sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, SUSPENSION / SOFT TISSUE | 15 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / TOPICAL | NA | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOAP / TOPICAL | 0.5 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| carboxymethylcellulose sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SYSTEM / TOPICAL | 1680 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| carboxymethylcellulose sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | AEROSOL, FOAM / VAGINAL | 0.2 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| icodextrin | ICODEXTRIN | 2NX48Z0A9G | TABLET, COATED / ORAL | 10 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| carboxymethylcellulose sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR | 25 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| carboxymethylcellulose sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, EXTENDED RELEASE / ORAL | 933 mg | ||
| carboxymethylcellulose sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | PASTE, DENTIFRICE / DENTAL | 1.2 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, EXTENDED RELEASE / ORAL | 450 mg | ||
| Calcium Phosphate, Dibasic, Anhydrous | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | CAPSULE, EXTENDED RELEASE / ORAL | 301.7 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / INTRAVENOUS | 0.2 %w/v | ||
| carboxymethylcellulose sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | CREAM / VAGINAL | 0.75 %w/w | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION, EXTENDED RELEASE / ORAL | 140.8 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| carboxymethylcellulose sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | CAPSULE / ORAL | 160 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / ORAL | 269 mg | ||
| dextrose | DEXTROSE | IY9XDZ35W2 | TABLET, EXTENDED RELEASE / ORAL | 103.95 mg | ||
| dextrose | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRAMUSCULAR | 5 %w/v | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 1 mg | ||
| cellulose, microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| icodextrin | ICODEXTRIN | 2NX48Z0A9G | TABLET / ORAL | 8 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SYSTEM / TRANSDERMAL | 35 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| carboxymethylcellulose sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION / OPHTHALMIC | 1 mg | ||
| carboxymethylcellulose sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 25 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Folic Acid | FOLIC ACID | REMEDYREPACK INC. | bda4687e-929a-434d-ab59-909cf2ed73a2 | 2026-09-11 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | REMEDYREPACK INC. | 368b69a8-a021-47e3-a6d7-e3497d7363b1 | 2026-09-04 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Rising Pharma Holdings, Inc. | 0baa10dd-6d1d-4946-8236-566451132da3 | 2026-07-24 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Northwind Health Company, LLC | 03b0aee4-804a-de63-e063-6394a90a6635 | 2026-07-13 | Warnings, Adverse reactions | FOLIC ACID |
| FOLIC ACID | FOLIC ACID | Unit Dose Solutions, Inc. | 54db8b21-87b9-5e0c-e063-6394a90ae8ea | 2026-06-22 | Warnings, Adverse reactions | FOLIC ACID |
| Vitramyn | FOLIC ACID | PureTek Corporation | c8af7616-5178-6df0-e053-2a95a90a334d | 2026-06-18 | Warnings, Adverse reactions | FOLIC ACID |
| FOLIC ACID | FOLIC ACID | Coupler LLC | 544e394d-3555-8ab1-e063-6394a90ade00 | 2026-06-15 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Major Pharmaceuticals | 7778ac96-7817-455a-a177-22ecb276c67f | 2026-05-26 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | QUAGEN PHARMACEUTICALS LLC | 354366ea-3702-4706-9fc0-0244b7278bd8 | 2026-05-20 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Cardinal Health 107, LLC | 624469a1-ded9-453a-973e-c5a2f0602bb0 | 2026-05-15 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Cardinal Health 107, LLC | 6dd867fe-597e-4915-8baf-98a605bf9324 | 2026-05-06 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | a1b71c5d-c842-43fd-9557-2bb4e934b914 | 2026-04-23 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Preferred Pharmaceuticals Inc. | b4c3a754-64cd-499a-a32f-a6e935c41355 | 2026-04-22 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Amneal Pharmaceuticals of New York LLC | fd85395e-6a0b-4072-a80b-36095c0c6dd6 | 2026-04-15 | Warnings, Adverse reactions | FOLIC ACID |
| Multitam | FOLIC ACID | PureTek Corporation | cee15842-4a9e-c6ba-e053-2a95a90aebc5 | 2026-04-13 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | XGen Pharmaceuticals DJB, Inc. | c5b2b84d-9f5e-4b81-ba10-9f2854e5dce9 | 2026-01-21 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Aphena Pharma Solutions - Tennessee, LLC | 40ab3c91-5a5b-fa1d-e063-6394a90a7454 | 2025-12-10 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | American Health Packaging | fc6dc1e1-f63e-4239-a1eb-67525569f68c | 2025-11-13 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | 4889d474-bd72-46ba-81d6-5511d8a85abb | 2025-11-04 | Warnings, Adverse reactions | FOLIC ACID |
| Folic Acid | FOLIC ACID | Bryant Ranch Prepack | 41914ac8-f4f5-4d70-b9f2-9f88c59d67a6 | 2025-10-29 | Warnings, Adverse reactions | FOLIC ACID |
Adverse event summaries are temporarily unavailable. Other product information remains available.